[Federal Register Volume 85, Number 61 (Monday, March 30, 2020)]
[Notices]
[Page 17583]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-06513]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2020-N-0008]


Allergenic Products Advisory Committee; Cancellation of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The meeting of the Allergenic Products Advisory Committee 
scheduled for May 15, 2020, is canceled. The Allergenic Products 
Advisory Committee meeting scheduled for May 15, 2020, to discuss and 
make recommendations on the safety and efficacy of Peanut (Arachis 
hypogaea) Allergen Extract manufactured by DBV Technologies, S.A, has 
been canceled to allow time for the FDA to review outstanding issues. 
The Agency intends to continue evaluating the product and will schedule 
an Advisory Committee meeting in the future, as needed. The meeting was 
announced in the Federal Register on February 24, 2020.

FOR FURTHER INFORMATION CONTACT: Kathleen Hayes, Center for Biologics 
Evaluation and Research, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 71, Rm. 6307, Silver Spring, MD 20993-0002, 301-
796-7864, kathleen.hayes@fda.hhs.gov, or FDA Advisory Committee 
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC 
area), and follow the prompts to the desired center or product area. 
Please call the Information Line for up-to-date information on this 
meeting, which was announced in the Federal Register of February 24, 
2020, 85 FR 10451.

    Dated: March 24, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020-06513 Filed 3-27-20; 8:45 am]
 BILLING CODE 4164-01-P


